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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S296Arthroplasty and arthrodesis, the standard treatments, were avoided. Iagh
treatment costs one-fourth the cost of the standard treatments and has no
side effects, complications or deaths.
Method: Pre-treatment evaluations included history, physical examina-
tion, MRI's, X-rays and blood tests including cbc, comprehensive metabolic
proﬁle, thyroid, IGf-1, and for females, estradiol, mammograms, CEA and
ca125; and for males psa and testerone. Sixty per cent of the joints
required arthroscopic debridement. Half of the patients required open
excision of an osteophyte on the dorsum of the talar neck which caused
impingement. Intra-articular injections of 5.0 mgm of Human Growth
hormone(Omnitrope, Sandoz) were give weekly for 5 to 12 weeks. I.A.
injections were made through an anterior approach after sterile prepara-
tion and local anesthetic injection in the subcutaneous tissue. No immo-
bilization was used. Patients were kept non weight bearing on the treated
side using 2 crutches and practiced active and passive assistive range of
motion exercises twice daily at home and for the duration of injections
plus an additional 4 weeks. Patients were encouraged to swim one hour
daily. During treatment a patellar tendon bearing(PTB) brace was con-
structed and carefully ﬁtted. This brace was worn for 6 months after
completion of injections. Continuous passive motion and physiotherapy
were not used.
Results: Evaluations were made with serial X-ray joint space measure-
ment; range of motion measurement with a goniometer; and visual
analogue scale for pain scores. Thirteen patients(93%) had good to
excellent results. One patient (7%) had no improvement and motion
remained 0 degrees. It is unknown whether this patient had additional
treatment in the future. Pain scores pre-treatment ranged from 4 /10 to 9
/10. Post-treatment pain scores ranged from 0/10 to 4/10; the average
loss of pain was 5 /10. Pre-treatment motion ranged from 0 to 30
degrees. Post-treatment motion ranged from 0 to 50 degrees with and
average of 14 degrees increase. There were no complications, side effects,
infections, increased stiffness or pain; DVT, pulmonary embolism; or
deaths.
Conclusion: 93% (13 of 14) of the patients treated with iagh injections
avoided arthroplasty and arthrodesis, the standard and more expensive
treatments. No patient became worse. The safety, high per cent. of success,
and its decreased cost recommends this treatment prior to considering
surgery. This is a Level IV Study.
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Purpose: The purpose of this study was to analysis the relationship
between the short-term results of unicondylar arthroplasty procedures
and obesity. Unicompartmental replacement of the osteoarthritic knee is
widely used in both the United States and Europe. Indications for uni-
compartmental knee arthroplasty usingminimally invasive techniques has
been expanded. The advantages of this concept that only the abnormal
joint surfaces are removed, the total amount of bone excised is minimal,
and the amount of foreign material is also minimal.
Methods: All the patients had predominantly unicompartmental knee
osteoarthritis. Obesity was deﬁned as body mass index (BMI) greater than
35 kg/m2. 96 unicondylar arthroplasties were performed in 2010 for
osteoarthritis at the Orthopedic Department. There were 62 women and
34 men. The average age was 62 years (range, 52 to 74 years). Only the
medial compartment was replaced. No other alternative procedures were
done on the patella. When associated patellofemoral osteoarthritis was
found total knee arthroplasty was performed. The follow-up examination
included the American Knee Society score, physical assessment, and
radiological evaluation. Pre-, post-operative and follow-up radiographs
were analyzed to assess further degenerative changes. The relationship
between the clinical result and body mass index was analysed.
Results: Thirtytwo patients had BMI's higher than 35 kg/m2, the
remaining 64 patients had lower BMIs. In both BMI group, 1-1 knees were
revised to total knee arthroplasty. The current two-year survival rate for
ﬁxed bearing unicondylar knee arthroplasty is 98%.
Conclusions: Properly selecting the patient for unicondylar knee arthro-
plasty is important in providing similar short term outcome for obese and
non-obese patients. The unicondylar knee arthroplasty is a less extensive
surgical option, which results in a faster postoperative recovery. It is
designed to treat knee joints with osteoarthritis limited to one compart-
ment. There was no signiﬁcant difference between the American Knee
Society scores between the two surviving BMI groups. All components
were radiographically stable.
